Key result
An 81-year-old male with hepatic angiosarcoma complicated by spontaneous hemoperitoneum experienced rapid clinical decline and died within months, highlighting the condition's poor prognosis.
Why the study?
Hepatic angiosarcoma is a rare malignancy, and hemoperitoneum is a frequent manifestation linked to higher mortality that remains underrecognized.
Case Report (n=1)
Highlights hemoperitoneum as a frequent, underrecognized, and high-mortality clinical manifestation of hepatic angiosarcoma.
Answers are grounded in this paper and cite their sources.
May prompt consideration of hepatic angiosarcoma in unexplained hemoperitoneum; single case leaves open need for larger studies on management.
Hepatic angiosarcoma (HA) is a rare primary malignancy of hepatic endothelial and fibroblastic vascular tissue origin. Patients typically present with vague constitutional symptoms of fatigue, weight loss, abdominal pain, and ascites. Hemoperitoneum is a frequent clinical manifestation of HA associated with higher mortality and is underrecognized. Here, we report the case of a patient with HA that was complicated by a peritoneal bleed, its management, and associated poor prognosis.
No takes yet. Share an insight, caveat, or question.
Afzal et al. (2023) conducted a case report in Hepatic angiosarcoma (n=1). Hepatic angiosarcoma was evaluated. An 81-year-old male with hepatic angiosarcoma complicated by spontaneous hemoperitoneum experienced rapid clinical decline and died within months, highlighting the condition's poor prognosis.
Synapse has enriched 10 related papers. Consider them for comparative context: